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Abstract
·This study aimed to assess the relationship between
the rate of nerve fiber loss in non -arteritic anterior
ischemic optic neuropathy (NAION) and time delay before
therapy. Total 24 patients received the same treatment
within or after 2wk (early and late groups). There were
significantly lower level of destruction of nerve fibers
( =0.0014) and significantly better visual field sensitivity
( =0.039) in early group. The results indicate that therapy
should be started within 2wk. The degree of ischemic
damage due to NAION correlates well with retinal nerve
fiber layer thickness and the ischemia-induced decrease
in visual field sensitivity.
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INTRODUCTION
A nterior ischemic optic neuropathy (AION) is the acuteischemia of the optic nerve head due to insufficient
blood supply by the short posterior ciliary arteries. Generally
divided into two types. The rare arteritic anterior ischemic
optic neuropathy (AAION) is associated with giant cell
arteritis. The non-arteritic anterior ischemic optic neuropathy
(NAION) is more common and is mainly related to the blood
flow defect of the short posterior ciliary arteries[1].
Blood supply to the optic nerve is uniquely complex
containing several collaterals. Due to the presence of several
collateral branches and a wide inter-individual variability the
degree of ischemic damage may vary considerably from
patient to patient[2].
In our study, we evaluated optic disc damage and
morphological changes during the procession of NAION. The
aim of this study was to assess the relationship between the
values of retinal nerve fiber layer (RNFL) and visual field
sensitivity, and the time delay before starting therapy.
SUBJECTS AND METHODS
All patients gave oral informed consent before enrolment.
The study was approved by the Ethical Committee of the
University of Debrecen. To exclude AAION, erythrocyte
sedimentation rate (ESR) and C-reactive protein (CRP)
values were determined. CRP levels above 0.5 mmol/L and
ESR values above 33 mm/h were taken to indicate vasculitis.
Enrolment was based on a review of our clinical patient
records to identify cases from the last 16y. Total 48
invitations have been send out for a control examination. Of
these cases, 5 patients died, 8 patients moved away and were
not able to reach, 6 patients did not want to participate in this
study, 3 patients had glaucoma and 2 patients had increased
CRP levels.
At last 28 NAION eyes of 24 patients (15 men and 9
women), who recieved the same therapy, were enrolled in the
study. The rest fellow eyes served as control.
After optic atrophy developed (min: 4y, average: 8.5y, SD:
3.99y) thorough ophthalmological examination, optical
coherence tomography (OCT; OCT3, Stratus, Zeiss
Meditech, Dublin, CA, USA) and visual field examinations
(Humphrey FDT perimeter, Zeiss Meditech, Dublin, CA,
USA) were performed.
The initiation of therapy depended on time when patients
presented at our department and not on randomization. Based
on this time our patients were divided into two groups. The
first group (early group) consisted of patients who had
received treatment within 2wk after NAION development
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(range: 1-13d, average: 6.57d, SD: 4.38d). The other group
(late group) comprised patients who had presented at our
clinic 2wk or later after NAION symptoms (range: 21-196d,
average: 76d, SD: 67.36d).
The two-group approach is part of the design for the sake of
clarity of presentation and description, while the analysis
itself is based on handling treatment delay as a continuous
variable in linear regression.
In the study, each patient underwent the same treatment for
5d: daily administration of 500 mg 6% hydroxyethyl starch
infusion, 2伊400 mg pentoxifylline infusion, 500 mg vitamin
C infusion, subcutaneous 50 IU/kg low-molecular-weight
heparin (LMWH), 250 mg acetazolamide and
100 mg aspirin.
For statistical analysis we used the RNFL average thickness
index and central retinal thickness (CRT) by OCT
examination, the decreased sensitivity (mean deviation, MD)
from visual field examination, and best corrected visual
acuity (BCVA, logMAR).
RESULTS
The mean age of the 24 patients (15 men and 9 women) was
66.6y (SD: 11.06y). No significant difference in age was
found between the early and the late groups (68.21依10.35y
64.19依12.06y, =0.45). The average follow-up period was
8.5依3.99y. During the follow-up period, 4 patients developed
bilateral NAION.
We evaluated the changes in visual acuity between the first
and the last examinations. Similarly to the Ischemic Optic
Neuropathy Decompression Trial (IONDT), a decrease of 0.3
logMAR corresponded to three lines better on the ETDRS
chart. At the first examination the average BCVA was 0.78
logMAR (0.73 logMAR in early group; 0.82 logMAR in late
group) (Table 1).
In both NAION groups RNFL showed significant decrease
compared to the control eyes ( =0.0004, and <0.0001).
We detected significantly higher nerve fiber destruction in the
late group comparing to the early group ( =0.0014) (Table 2).
Analyzing the effect of duration of treatment as a continuous
variable and adjusted for age, gender, and cardiovascular risk
score, with each unit increase in log-transformed number of
days ( a 2.718-fold increase in number of days), the RNFL
parameter was estimated to decrease by 5.812 滋m (95%CI:
3.09 to 8.53, <0.0001) (Figure 1).
MD values associated with the decrease in visual field
sensitivity showed a significant difference compared to the
fellow eyes ( <0.001) and also between the two groups
( =0.039). Adjusted for age, gender and cardiovascular risk
score, a visual field sensitivity reduction of 2.01 (95% CI:
0.29 to 3.74; =0.0217) units was associated with each unit
increase in log-day of treatment onset.
Regarding CRT, no significant difference was found either
compared to the control group ( =0.451), between the
treated groups ( =0.519), or in relation to quantified
treatment delay ( =0.399).
In visual acuity (logMAR) analysis, significant deviations
were observed compared to control eyes (0.06依0.23) in the
early group (0.57依0.59) and in the late group (0.74依0.54)
( =0.007, 0.0002, respectively). However, the difference
between the two treatment groups was not significant ( =
0.31), and neither was the adjusted effect of treatment delay
( =0.550).
Comparing the unaffected fellow-eyes of patients in early and
late groups RNFL, CRT, visual field sensitivity and visual
acuity showed normal and very closely similar values.
-values were between 0.87 and 0.95.
CONCLUSION
Due to complex circulatory conditions, the destruction of the
optic nerve fibers does not occur immediately in NAION.
The correction of microcirculation disturbances at an early
stage can minimize the degree of nerve fiber loss[2]. Ischemic
axoplasmic damage plays an important role in the
pathogenesis of NAION. The swelling may compromise
capillaries; the increased vessel permeability due to the stasis
enhances the edema, which further reduces axoplasmic flow,
leading to a vicious cycle[3].
Numerous treatments have been investigated, although the
exact therapy still remains unclear [4]. We designed our
therapy based on our experiences with NAION patiens and
considering the results of international studies.
In our study, OCT and visual field deviations demonstrated a
significant difference between early and late groups (Table 2).
We used statistical modeling to determine the relationship
Table 1 Changes in visual acuity between first and last 
examination in the early and late group                    % 
Patients ≥3 lines better Little change  ≥3 lines worse 
Early group 42.9 42.9 14.2 
Late group 21.4 57.2 21.4 
Decrease of 0.3 logMAR corresonded to three lines better on the 
ETDRS chart. 
 
Figure 1 Post -treatment RNFL thickness plotted against the
number of days before treatment onset Linear regression
adjusted for age and gender; line fitted at average age and gender.
CI: Confidence interval.
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between the extent of fiber destruction and the quantitatively
handled amount of time elapsing before treatment onset
(Figure 1). The statistically highly significant 5.8 滋m
difference associated with each log-day increase is a finding
of strong clinical importance. These results suggest that
treatment for improving blood circulation is recommended as
early as possible.
Regarding visual field defects, we carried out a similar
analysis and found that the later the treatment started, the
greater the sensitivity reduction in the visual field was: the
parameter decreased by 2.01 units with each log-day. This
identifies an important functional domain where early
intervention potentially translates to improved clinical
outcomes.
Visual loss showed no significant difference between the two
groups. Our results correlated well with those by Hayreh and
Zimmerman[5], demonstrating that good visual acuity does not
preclude NAION diagnosis and gives no information about
visual field defects, which are of a greater diagnostic value.
It is well documented that RNFL thickness decreases with
age [6]. In our study the patients in both groups were of nearly
the same age (68.21 64.19y, =0.45), so age is not
likely to have affected the differences in RNFL values
between the groups. Comparing the fellow eyes of both
groups, all parameter (RNFL, CRT, visual field sensitivity
and BCVA) showed normal and very closely similar. Jonas
[7] and Budenz [8] analized the optic disc C/D ratio
and RNFL in normal eyes. There were no statistically
significant relationships between the side of eye. These
findings and our results support the assumption that the
decreased parameter values of NAION eyes are not random
but really the consequence of ischemic damage.
We have investigated the degree of fiber loss in NAION in
relation to the onset time of therapy. The earliest possible
restoration of blood supply in ischemic events is fundamental
in terms of the later outcome of the disease. Our study
demonstrates that conservative therapy started as early as
possible (within two weeks) can significantly reduce the
degree of optical nerve fiber loss and the visual field
sensitivity deficit. The applied circulatory improving therapy
can be effective in NAION. We are the first to demonstrate
that optimal timing of the first line therapy is within two
weeks, as late-initiated therapy cannot effectively prevent and
stop the destruction of the optical nerve.
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Table 2 RNFL, CRT, average decrease of visual field sensitivity, BCVA in NAION eyes treated at different times, and in 
unaffected fellow eyes 
Patients RNFL (µm) CRT (µm) Visual field sensitivity (MD) BCVA (logMAR) 
Early group 54.5±15.6 203±33.6 -20.17±10.2 0.59±0.6 
Late group 37.54±8.2 195.7±17.7 -26.8±4.5 0.74±0.54 
Fellow eyes 78.39±24.7 204.9±26.2 -7.61±8.4 0.018±0.41 
aP (all NAION vs fellow eyes) <0.0001 0.254 <0.0001 0.0002 
bP (early vs late group) 0.0014 0.519 0.039 0.31 
aAll NAION vs fellow eyes; bEarly vs late group; Values of P<0.05 are considered to be significant. 
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